A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia

NCT00699348 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Methoxy polyethylene glycol-epoetin beta (C.E.R.A.)

Sponsor

Hoffmann-La Roche